The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
Primary objectives: Use both listed and relatively safe drug, Silymarin,s to improve the
intestinal side effect of the patients undergoing FOLFIRI chemotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital